RUNX1 and myelodysplastic syndrome: The most common translocations involving RUNX1 include t(12;21) observed in 25 % of pediatric acute lymphoblastic leukemia (ALL), t(8; 21) in 10 % of adult AML, and t(3;21) in therapy-related AML and myelodysplastic syndrome (MDS).